Stock Screener App

無料 - Play StoreApp Store

インストールインストール

KRSA

$31.032.91%-0.93

アフターアワーズ： 31.66+0.63 +2.03%

Korsana Biosciences, Inc. Common Stock (KRSA)

Date: O: H: L: C: Vol:

Korsana Biosciences, Inc. Common Stock (KRSA) 最新ニュース

Korsana Biosciences (KRSA) Stock Price, News & Analysis - Stock Titan

Can Tenet Healthcare Beat Q3 Earnings on Ambulatory Care Strength? - Zacks Investment Research

Form 144 KORSANA BIOSCIENCES For: 22 October By Investing.com - Investing.com Nigeria

Form 144 KORSANA BIOSCIENCES For: 22 October By Investing.com - Investing.com Canada

Form 144 KORSANA BIOSCIENCES For: 22 October By Investing.com - Investing.com UK

Korsana Biosciences Schedules Special Shareholder Vote on Cayman Islands Redomestication - Kalkine Media

A 25,974-share stake in Korsana Biosciences (KRSA) is held by J. Wood Capital Advisors. - Stock Titan

A passive stake above 5% in Korsana Biosciences (KRSA) is reported by FMR LLC in an amendment. - Stock Titan

Directors would get staggered three-year terms under Korsana Biosciences (Nasdaq: KRSA)'s proposed move. - Stock Titan

Korsana Biosciences (NASDAQ: KRSA) director to sell 100 more shares after 2,139 sold recently - Stock Titan

After two September sales, a Korsana Biosciences (KRSA) director proposes selling 4,903 more shares. - Stock Titan

What is the current Price Target and Forecast for Korsana Biosciences, Inc. (KRSA) - Zacks Investment Research

General Atlantic’s stake in Korsana (CYCN) comes with a strict ownership cap - Stock Titan

Korsana Biosciences (CYCN) director proposes $74.8K stock sale - Stock Titan

A fund reports a 6.1% passive stake in Korsana Biosciences (CYCN), with the investor's identity detailed in the filing. - Stock Titan

Nearly 10% of Korsana Biosciences (CYCN) is tied to one investor group, but its ownership is capped below that line. - Stock Titan

Diluted net income available to common stockholders of Korsana Biosciences, Inc. – NASDAQ:KRSA - TradingView

Korsana Biosciences, Inc. Statistics – NASDAQ:KRSA - TradingView

KRSA Forecast — Price Target — Prediction for 2027 - TradingView

Korsana Biosciences Completes Merger and Nasdaq Listing - TipRanks

Korsana Biosciences, Inc. (KRSA) stock price, news, quote and history - Yahoo Finance UK

Investor gains significant stake and board power at Korsana Biosciences (CYCN) - Stock Titan

Korsana Biosciences, Inc. (KRSA) Company Information - Simply Wall Street

Why a 9.99% cap now limits a key Korsana (CYCN) holder - Stock Titan

CFO option stakes detailed at Korsana Biosciences (CYCN) after merger - Stock Titan

Merger gives Korsana Biosciences (CYCN) CMO options expiring in 2036 - Stock Titan

Korsana Biosciences (CYCN) director holds merger-issued option - Stock Titan

New Korsana Biosciences (CYCN) director reports 28,805-share option - Stock Titan

Korsana Biosciences Completes Cyclerion Merger And $380 Million Private Placement - Pulse 2.0

KRSA Stock Price and Chart — NASDAQ:KRSA - TradingView

Korsana Biosciences Completes Closing of Merger with Cyclerion Therapeutics and Previously Announced Private Placement of $380 Million - The Manila Times

Patient data from an Alzheimer’s drug is anticipated by late 2027 or early 2028 - Stock Titan

Korsana Biosciences Strengthens Leadership with Executive and Board Appointments to Support Next Phase of Growth - BioSpace

Korsana Biosciences Appoints Matthew Leoni, M.D., Gan Wei, Ph.D., and Heidi Henson as Company Advances Alzheimer’s Program - citybiz

TRAX Stock Price and Chart — NASDAQ:TRAX - TradingView

Deal Dispatch: McCormick, Unilever Merge, Sysco Acquires Jetro Restaurant Depot For $29 Billion, QVC Cons - Benzinga

CYCN Stock Explodes 313% on April 1 After Cyclerion-Korsana Merger Deal for Alzheimer's Pipeline - International Business Times Australia

Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement - BioSpace

Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement - Business Wire

Why is Biotech Stock Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) Gaining? - Investorideas.com

Cyclerion Therapeutics and Korsana Biosciences To Merge - citybiz

Cyclerion Therapeutics and Korsana Biosciences to merge - The Pharma Letter

CYCN Merges with Korsana Biosciences for Strategic Growth - GuruFocus

Cyclerion Therapeutics Stock Soars 350% On Korsana Merger, $380 Million Financing - Benzinga

Cyclerion provides public listing vehicle for Korsana in $380M deal - The Business Journals

Alzheimer's-focused Korsana uses Cyclerion merger to go public - Fierce Biotech

Cyclerion Therapeutics (CYCN) Stock Price, News & Analysis - Stock Titan

TYRA Stock Price and Chart — NASDAQ:TYRA - TradingView

NUVB Stock Price and Chart — NYSE:NUVB - TradingView

INBX Stock Price and Chart — NASDAQ:INBX - TradingView

KRSAに類似

LYCA$27.201.45%

AAPG$15.2012.76%

ANAB$46.991.55%

KARD$15.004.75%

MLYS$16.181.19%

RAPP$25.781.34%